|
|
||||||||
Pathogenicity and Medical Microbiology |
-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans
Department of Anti-infectives Research1, Center for Molecular Design2, Department of Biotechnology3 and Department of Functional Genomics4, Janssen Research Foundation, Turnhoutseweg 30, B2340 Beerse, Belgium
Department of Molecular Cell Biology and Genetics, University of Maastricht, The Netherlands5
Author for correspondence: Patrick Marichal. Tel: +32 14 60 31 97. Fax: +32 14 60 54 03. e-mail: pmaricha{at}janbe.jnj.com
The cytochrome P450 14
-demethylase, encoded by the ERG11 (CYP51) gene, is the primary target for the azole class of antifungals. Changes in the azole affinity of this enzyme caused by amino acid substitutions have been reported as a resistance mechanism. Nine Candida albicans strains were used in this study. The ERG11 base sequence of seven isolates, of which only two were azole-sensitive, were determined. The ERG11 base sequences of the other two strains have been published previously. In these seven isolates, 12 different amino acid substitutions were identified, of which six have not been described previously (A149V, D153E, E165Y, S279F, V452A and G465S). In addition, 16 silent mutations were found. Two different biochemical assays, subcellular sterol biosynthesis and CO binding to reduced microsomal fractions, were used to evaluate the sensitivity of the cytochromes for fluconazole and itraconazole. Enzyme preparations from four isolates showed reduced itraconazole susceptibility, whereas more pronounced resistance to fluconazole was observed in five isolates. A three-dimensional model of C. albicans Cyp51p was used to position all 29 reported substitutions, 98 in total identified in 53 sequences. These 29 substitutions were not randomly distributed over the sequence but clustered in three regions from amino acids 105 to 165, from 266 to 287 and from 405 to 488, suggesting the existence of hotspot regions. Of the mutations found in the two N-terminal regions only Y132H was demonstrated to be of importance for azole resistance. In the C-terminal region three mutations are associated with resistance, suggesting that the non-characterized substitutions found in this region should be prioritized for further analysis.
Keywords: itraconazole, fluconazole, resistance, Erg11p, modelling
The GenBank accession numbers for the sequences reported in this paper are AF153844AF153850.
This article has been cited by other articles:
![]() |
A. R. Brown, D. J. Hosken, F. Balloux, L. K. Bickley, G. LePage, S. F. Owen, M. J. Hetheridge, and C. R. Tyler Genetic variation, inbreeding and chemical exposure--combined effects in wildlife and critical considerations for ecotoxicology Phil Trans R Soc B, November 27, 2009; 364(1534): 3377 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Arana, C. Nombela, and J. Pla Fluconazole at subinhibitory concentrations induces the oxidative- and nitrosative-responsive genes TRR1, GRE2 and YHB1, and enhances the resistance of Candida albicans to phagocytes J. Antimicrob. Chemother., November 6, 2009; (2009) dkp407v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Posteraro, R. Martucci, M. La Sorda, B. Fiori, D. Sanglard, E. De Carolis, A. R. Florio, G. Fadda, and M. Sanguinetti Reliability of the Vitek 2 Yeast Susceptibility Test for Detection of In Vitro Resistance to Fluconazole and Voriconazole in Clinical Isolates of Candida albicans and Candida glabrata J. Clin. Microbiol., June 1, 2009; 47(6): 1927 - 1930. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cannon, E. Lamping, A. R. Holmes, K. Niimi, P. V. Baret, M. V. Keniya, K. Tanabe, M. Niimi, A. Goffeau, and B. C. Monk Efflux-Mediated Antifungal Drug Resistance Clin. Microbiol. Rev., April 1, 2009; 22(2): 291 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Eddine, J. P. von Kries, M. V. Podust, T. Warrier, S. H. E. Kaufmann, and L. M. Podust X-ray Structure of 4,4'-Dihydroxybenzophenone Mimicking Sterol Substrate in the Active Site of Sterol 14{alpha}-Demethylase (CYP51) J. Biol. Chem., May 30, 2008; 283(22): 15152 - 15159. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Cowen and W. J. Steinbach Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance Eukaryot. Cell, May 1, 2008; 7(5): 747 - 764. [Full Text] [PDF] |
||||
![]() |
C.-X. Luo and G. Schnabel The Cytochrome P450 Lanosterol 14{alpha}-Demethylase Gene Is a Demethylation Inhibitor Fungicide Resistance Determinant in Monilinia fructicola Field Isolates from Georgia Appl. Envir. Microbiol., January 15, 2008; 74(2): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Coste, A. Selmecki, A. Forche, D. Diogo, M.-E. Bougnoux, C. d'Enfert, J. Berman, and D. Sanglard Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates Eukaryot. Cell, October 1, 2007; 6(10): 1889 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mellado, G. Garcia-Effron, L. Alcazar-Fuoli, W. J. G. Melchers, P. E. Verweij, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1897 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng, C. J. Clancy, K. T. Nguyen, W. Clapp, and M. H. Nguyen A Candida albicans Petite Mutant Strain with Uncoupled Oxidative Phosphorylation Overexpresses MDR1 and Has Diminished Susceptibility to Fluconazole and Voriconazole Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1855 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Coste, V. Turner, F. Ischer, J. Morschhauser, A. Forche, A. Selmecki, J. Berman, J. Bille, and D. Sanglard A Mutation in Tac1p, a Transcription Factor Regulating CDR1 and CDR2, Is Coupled With Loss of Heterozygosity at Chromosome 5 to Mediate Antifungal Resistance in Candida albicans Genetics, April 1, 2006; 172(4): 2139 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vandeputte, G. Larcher, T. Berges, G. Renier, D. Chabasse, and J.-P. Bouchara Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis Antimicrob. Agents Chemother., November 1, 2005; 49(11): 4608 - 4615. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chau, M. Gurnani, R. Hawkinson, M. Laverdiere, A. Cacciapuoti, and P. M. McNicholas Inactivation of Sterol {Delta}5,6-Desaturase Attenuates Virulence in Candida albicans Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3646 - 3651. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Osborne, I. Leitner, B. Favre, and N. S. Ryder Amino Acid Substitution in Trichophyton rubrum Squalene Epoxidase Associated with Resistance to Terbinafine Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2840 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pinjon, C. J. Jackson, S. L. Kelly, D. Sanglard, G. Moran, D. C. Coleman, and D. J. Sullivan Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1312 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Lo, J.-S. Wang, C.-Y. Lin, C.-G. Chen, T.-Y. Hsiao, C.-T. Hsu, C.-L. Su, M.-J. Fann, Y.-T. Ching, and Y.-L. Yang Efg1 Involved in Drug Resistance by Regulating the Expression of ERG3 in Candida albicans Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1213 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. da Silva Ferreira, J. L. Capellaro, E. dos Reis Marques, I. Malavazi, D. Perlin, S. Park, J. B. Anderson, A. L. Colombo, B. A. Arthington-Skaggs, M. H. S. Goldman, et al. In Vitro Evolution of Itraconazole Resistance in Aspergillus fumigatus Involves Multiple Mechanisms of Resistance Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4405 - 4413. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mellado, G. Garcia-Effron, L. Alcazar-Fuoli, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela Substitutions at Methionine 220 in the 14{alpha}-Sterol Demethylase (Cyp51A) of Aspergillus fumigatus Are Responsible for Resistance In Vitro to Azole Antifungal Drugs Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2747 - 2750. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Chau, C. A. Mendrick, F. J. Sabatelli, D. Loebenberg, and P. M. McNicholas Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2124 - 2131. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Lee, L. E. Williams, D. W. Warnock, and B. A. Arthington-Skaggs Drug resistance genes and trailing growth in Candida albicans isolates J. Antimicrob. Chemother., February 1, 2004; 53(2): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, N. Brown, A. S. Chau, J. L. Lopez-Ribot, M. T. Ruesga, G. Quindos, C. A. Mendrick, R. S. Hare, D. Loebenberg, B. DiDomenico, et al. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans J. Antimicrob. Chemother., January 1, 2004; 53(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pinjon, G. P. Moran, C. J. Jackson, S. L. Kelly, D. Sanglard, D. C. Coleman, and D. J. Sullivan Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2424 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Morales, P. K. Vohra, V. Puri, T. J. Kottom, A. H. Limper, and C. F. Thomas Jr. Characterization of a Lanosterol 14{alpha}-Demethylase from Pneumocystis carinii Am. J. Respir. Cell Mol. Biol., August 1, 2003; 29(2): 232 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Burger, S. Rondet, P. Benveniste, and H. Schaller Virus-induced silencing of sterol biosynthetic genes: identification of a Nicotiana tabacum L. obtusifoliol-14{alpha}-demethylase (CYP51) by genetic manipulation of the sterol biosynthetic pathway in Nicotiana benthamiana L. J. Exp. Bot., July 1, 2003; 54(388): 1675 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Guengerich Cytochromes P450, Drugs, and Diseases Mol. Interv., June 1, 2003; 3(4): 194 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukuoka, D. A. Johnston, C. A. Winslow, M. J. de Groot, C. Burt, C. A. Hitchcock, and S. G. Filler Genetic Basis for Differential Activities of Fluconazole and Voriconazole against Candida krusei Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1213 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Diaz-Guerra, E. Mellado, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela A Point Mutation in the 14{alpha}-Sterol Demethylase Gene cyp51A Contributes to Itraconazole Resistance in Aspergillus fumigatus Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1120 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Mann, R. M. Parmegiani, S.-Q. Wei, C. A. Mendrick, X. Li, D. Loebenberg, B. DiDomenico, R. S. Hare, S. S. Walker, and P. M. McNicholas Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14{alpha}-Demethylase Antimicrob. Agents Chemother., February 1, 2003; 47(2): 577 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kobayashi, K. Kondo, N. Uehara, S. Otokozawa, N. Tsuji, A. Yagihashi, and N. Watanabe Endogenous Reactive Oxygen Species Is an Important Mediator of Miconazole Antifungal Effect Antimicrob. Agents Chemother., October 1, 2002; 46(10): 3113 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perea, J. L. Lopez-Ribot, B. L. Wickes, W. R. Kirkpatrick, O. P. Dib, S. P. Bachmann, S. M. Keller, M. Martinez, and T. F. Patterson Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1695 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakayama, N. Nakayama, M. Arisawa, and Y. Aoki In Vitro and In Vivo Effects of 14alpha -Demethylase (ERG11) Depletion in Candida glabrata Antimicrob. Agents Chemother., November 1, 2001; 45(11): 3037 - 3045. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Perea, J. L. Lopez-Ribot, W. R. Kirkpatrick, R. K. McAtee, R. A. Santillan, M. Martinez, D. Calabrese, D. Sanglard, and T. F. Patterson Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients Antimicrob. Agents Chemother., October 1, 2001; 45(10): 2676 - 2684. [Abstract] [Full Text] |
||||
![]() |
E. Mellado, T. M. Diaz-Guerra, M. Cuenca-Estrella, and J. L. Rodriguez-Tudela Identification of Two Different 14-{alpha} Sterol Demethylase-Related Genes (cyp51A and cyp51B) in Aspergillus fumigatus and Other Aspergillus species J. Clin. Microbiol., July 1, 2001; 39(7): 2431 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Podust, T. L. Poulos, and M. R. Waterman Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors PNAS, March 13, 2001; 98(6): 3068 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Marr, C. N. Lyons, K. Ha, T. R. Rustad, and T. C. White Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans Antimicrob. Agents Chemother., January 1, 2001; 45(1): 52 - 59. [Abstract] [Full Text] |
||||
![]() |
H. Kakeya, Y. Miyazaki, H. Miyazaki, K. Nyswaner, B. Grimberg, and J. E. Bennett Genetic Analysis of Azole Resistance in the Darlington Strain of Candida albicans Antimicrob. Agents Chemother., November 1, 2000; 44(11): 2985 - 2990. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |